人参总皂苷对体外培养肌管形态及Atrogin-1表达的影响  

Effects of Ginsenosides for the Cultured Myotube's Morphology and the Expression of Atrogin-1

作　　者：许烨[1] 丁婷婷[1] 王会玲[1] 张金元[1] 

机构地区：[1]中国人民解放军第四五五医院肾脏科,南京军区肾脏病研究所,上海200052

出　　处：《中国中西医结合肾病杂志》2012年第8期666-668,I0001,共4页Chinese Journal of Integrated Traditional and Western Nephrology

基　　金：上海市浦江人才基金资助项目(No.10PJD016);上海市启明星跟踪基金资助项目(No.07QH14020)

摘　　要：目的:慢性肾衰竭(CKD)尤其进入终末期透析的患者常并发以骨骼肌蛋白质-能量消耗为特征的营养不良,研究表明Atrogin-1激活是肌肉蛋白分解的关键步骤。本实验通过培养肌细胞,观察人参总皂苷的干预下,对糖皮质激素作用下肌细胞形态改变及Atrogin-1的表达的影响。方法:培养小鼠肌原细胞C2C12并使之融合成肌管,以不同浓度的地塞米松(0～10μm)和人参总皂苷(100μmol/L)刺激肌管后,镜下观察肌管形态改变,Westernblot检测Atrogin-1蛋白表达水平。结果:糖皮质激素地塞米松作用下,可剂量依赖性地使肌管变细,肌管Atrogin-1蛋白表达水平显著增高;在人参总皂苷干预后,肌管形态较地塞米松组增粗,同时肌管Atrogin-1蛋白降低(P<0.05)。结论:人参总皂苷能够改善地塞米松作用下肌肉消耗,并下调肌管Atrogin-1蛋白表达水平。Objective：Patients with chronic kidney disease （CKD） often complicated with malnutrition which characteristic skeletal muscle protein energy wasting. Early studies suggested that a key procedure was Atrogin - 1 activation induced muscle pro- teins breakdown. In the present experiments, we observed the effects of ginsenosides for the myotube＇ s morphology and the Atrogin - 1 expression treated with exogenous glucocorticoids （dexamethasone）. Methods：Cultured mouse C2C12 myogenous cells and fused into myotubes, then treated with different concentrations of dexamethasone （0 - 10 Ixmol/L） and ginsenosides （100 p^mol/L）, ob- served myotube＇ s morphology by light microscopy, the protein expression of Atrogin - 1 was measured by Western blot. Results： After treated with glucocorticoids, the myotube became thinner in a dose - dependent, and the expression of Atrogin - 1 protein increased significantly （P 〈0.01 ）. With the intervention of ginsenosides, the myotubes size was thicker compared with the dexamethasone groups, and the Atrogin -1 protein was decreased （P 〈 0.01 ）. Conclusion：The Ginsenosides can rescue the muscle wasting, and down - regulating Atrogin - 1 protein expression induced by glucocorticoids.

关 键 词：骨骼肌 萎缩 人参皂苷 ATROGIN-1 

分 类 号：R285.5[医药卫生—中药学]